Anxo Pharmaceutical Co., Ltd. (TPEX:6677)

Anxo Pharmaceutical Revenue

In the year 2025, Anxo Pharmaceutical had annual revenue of 843.26M TWD, down -5.81%. Anxo Pharmaceutical had revenue of 440.48M in the half year ending December 31, 2025, a decrease of -10.97%.

• Revenue: 843.26M
• Revenue Growth: -5.81%
• P/S Ratio: 1.17
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 988.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	843.26M	-52.06M	-5.81%
Dec 31, 2024	895.32M	-44.62M	-4.75%
Dec 31, 2023	939.94M	73.67M	8.50%
Dec 31, 2022	866.27M	42.17M	5.12%
Dec 31, 2021	824.10M	-42.01M	-4.85%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 28, 2026

Data Sources Report a data error